- The Wall Street Journal•5 hours ago
Call 2016 the year of the megadeal in health-care venture capital.
- Market Realist•6 hours ago
In 4Q16, Eli Lilly (LLY) reported Basaglar sales of $40 million from Japan and several European markets.
- Market Realist•7 hours ago
Erbitux's sales fell 13% to $153.7 million in 4Q16, compared to ~$176.2 million in 4Q15.
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||82.66 - 83.40|
|52 Week Range||64.18 - 83.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.22|
|Dividend & Yield||2.08 (2.51%)|
|1y Target Est||N/A|